HOME › DRUGS › INSULIN GLARGINE;LIXISENATIDE
ACTIVE SUBSTANCE / INN

INSULIN GLARGINE;LIXISENATIDE

Brand name(s): Suliqua
EMA LISTED
AUTHORISED
Diabetes Mellitus, Type 2
ACTIVE SUBSTANCE
Insulin Glargine;Lixisenatide
REGULATORS
EMA
SPONSORS / MAH
Sanofi Winthrop Industrie
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
SuliquaSanofi Winthrop IndustrieAuthorised11/01/2017Diabetes Mellitus, Type 2

FULL INTELLIGENCE ON INSULIN GLARGINE;LIXISENATIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →